Seattle Genetics

Biotech Corner: Monoclonal Antibody Companies

Biotech Corner: Monoclonal Antibody Companies

Seeking Alpha

Seattle Genetics to test possible new Adcetris use in late-stage study

Seattle Genetics to test possible new Adcetris use in late-stage study

Yahoo/AP

Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Data in CD30-Positive Non-Hodgkin Lymphomas and Other Malignancies from Multiple Presentations at ASH Annual Meeting

Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Data in CD30-Positive Non-Hodgkin Lymphomas and Other Malignancies from Multiple Presentations at ASH Annual Meeting

Yahoo/BusinessWire

Seattle Genetics: A Short Thesis That's Been Right And Wrong

Seattle Genetics: A Short Thesis That's Been Right And Wrong

TheStreet.com

Seattle Genetics

3 Things to Watch With Seattle Genetics

3 Things to Watch With Seattle Genetics

Motley Fool

Seattle Genetics

3 Things to Watch With Celldex Therapeutics

3 Things to Watch With Celldex Therapeutics

Motley Fool

AstraZeneca Suspends The Buyback: Let The M&A Speculation Commence

AstraZeneca Suspends The Buyback: Let The M&A Speculation Commence

Seekin Alpha

PDL BioPharma CEO Explains Strategy To Maintain Dividend With Significant Growth

PDL BioPharma CEO Explains Strategy To Maintain Dividend With Significant Growth

Seeking Alpha

Six Disruptive Biotech Stocks

Six Disruptive Biotech Stocks

Motley Fool